Post on 14-Dec-2015
La Nanomedicina
Prof. Dr. Josep Samitier Univ. De Barcelona
Lab Nanobioingeniería (IBEC)Coordinador Plataforma Española de Nanomedicina
Director Adjunto CIBER BBN
MiniaturizaciónTécnicas clásicas (Macro)
Microdispositivos
Nanotecnología
Convergencia de tecnologías
Nuevas Tecnologías
Richard Feynman
Definition: NanoMedicine, for the purpose of this vision document, is defined as the application of Nanotechnology to Health. It exploits the improved and often novel physical, chemical, and biological properties of materials atthe nanometric scale. NanoMedicine has potential impact on the prevention, early and reliable diagnosis and treatment of diseases.
ETP on Nanomedicine
Entorn internacional
• NIH Nanomedicine Roadmap Initiative, emprendida por el Instituto Nacional de Salud de EE.UU en mayo de 2004 (http://www.capconcorp.com/roadmap04/)
• ESF Scientific Forward Look on Nanomedicine, presentado por el comité de expertos de la European Science Foundation en febrero de 2005 (http://www.esf.org/newsrelease/83/SPB23Nanomedicine.pdf)
• EuroNanoForum 2005, Nanotechnology and the Health of the EU Citizen in 2020 (Edimburgo, 6 – 9 septiembre de 2005).
PLATAFORMA ESPAÑOLA DE
NANOMEDICINA
Jornadas de Plataformas Tecnológicas
Josep Samitier
Parc Científic de Barcelona-Univ. de Barcelona
Institut de Bioenginyeria de Catalunya (IBEC)
GRUPOS DE TRABAJO
Nanodiagnóstico
Medicina Regenerativa
Liberación de Fármacos
Medicina Regenerativa20%
Educación/ Comunicación22%
Nanodiagnóstico17%
Toxicidad/ Regulación24%
Liberación de fármacos17%
Educación / Comunicación
Toxicidad / Regulación
Por Comunidades Autónomas
Catalunya25%
Galicia7%
Madrid28%
País Vasco18%
C. Valenciana6%
Navarra1%
Canarias1% Andalucía
11% Aragon2%
Asturias1%
MIEMBROS
EURONANOBIO WP1 Experts WorkshopNanobio Clusters: identifying best practices
Dr Arantxa Sanz Prof. Josep Samitier
Institute for Bioengineering of Catalonia (IBEC)Barcelona, SPAIN
WP1:OBJECTIVES AND METHOD
GLOBAL OBJECTIVE: Identifying best practices across the most successful clusters
As integration is key to success in nanobio, success = high quality, common research projects and results (with diverse cluster members as partners)
DATA COLLECTION and ANALYSIS: METHODOLOGY (Feb-May 09)• Definition of a nanobio cluster in the study: research vs innovation cluster• Mapping clusters elsewhere: USA, Canada, Asia-Pacific• Mapping clusters in Europe• Identifying best practices via SWOT analysis • Consolidation workshop: discussion and brainstorming
USA: mapping preliminary results
Research
Clinical
Cluster agency
Innovation
Cluster agency non specific
BAY AREA
SOUTH CALIFORNIA
HOUSTON
CHICAGO
BOSTON
CORNELL
N. CAROLINA
…
ASIA PACIFIC – preliminary results
Research
Clinical
Cluster agency
Innovation
Cluster agency non specific
TSUKUBA / TOKYO
KOBE
YONSEI (SEOUL)
SINGAPORE
SIDNEY …
European Union: mapping preliminary results
Most advanced nanobio clusters across EU + associate states:
-Higher integration level of actors, including hospitals
-Remarkable common output in terms of funded projects, research papers and patents / creation of spin off companies
Research
Clinical
Cluster agency
Innovation
Cluster agency non specific
SWOT analysis: Applying criteria for case studies
STRENGTHS First-class medical researchMaterials science tradition and expertise from oil industryUniversity of Texas system Clinical transfer
WEAKNESSES Number of spin off companies/ Innovation levels: not as high as they might be (compared to California, Massachussets, Chicago)
OPPORTUNITIES Alliance for Nanohealth NIH programme. Purdue Centre of Excellence
THREATSVery specialized on cancer but it cannot be the only one – see the distributed NIH network Health system ???
HOUSTON
SWOT analysis for the mapped clusters (some examples…)
STRENGTHSBioAnalytik Munster: Facilitator, coordinatorIntegration of excellent academic and clinical research Good levels of partnership with industry: Tradition in instrumentationInnovation/ Tech transfer: nanobio start ups
WEAKNESSES Talent attraction : not a capital city
OPPORTUNITIES Very strong support from local government (Munster City council): BrandingSocial capital: easy to network and meet
THREATENSNational support: Other competitive German clusters
MÜNSTER – EXAMPLE